The acquisition battle between global pharmaceutical giants Pfizer and Novo Nordisk over the bio company Metsera is ...

Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO ...

Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC ...

For the first time in years, the obesity rate is falling in the US, with the rise of weight loss injections like Ozempic and ...

With a new generation of weight-loss drugs entering Indian markets, spelling hope for many, The Indian Express tracks the ...

Many doctors and patients came to believe the rise in obesity may be all but biologically inescapable, despite the grave ...

Exclusive: Australian doctors are being approached every day by teenagers and young adults – girls as well as boys – asking ...

The UK Government is funding a study which will involve 5,000 people from some of Scotland’s most deprived areas being given Wegovy injections.

Determined to "live as a healthy father," I administered my first injection of the lowest dose ... participants achieving ...

Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion ...

Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, has announced an unsolicited bid to ...

A major international study led by researchers at University College London has found that semaglutide, the active ingredient in Ozempic and Wegovy, may protect the heart even when users lose little ...